Dyspareunia epidemiology and demographics

Jump to navigation Jump to search

Dyspareunia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Dyspareunia from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Dyspareunia epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Dyspareunia epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Dyspareunia epidemiology and demographics

CDC on Dyspareunia epidemiology and demographics

Dyspareunia epidemiology and demographics in the news

Blogs on Dyspareunia epidemiology and demographics

Directions to Hospitals Treating Dyspareunia

Risk calculators and risk factors for Dyspareunia epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Jesus Rosario Hernandez, M.D. [2]


Overview

The prevalence of dyspareunia is estimated to vary from 3 to 18% worldwide.

Epidemiology and Demographics

Incidence

Prevalence

The prevalence of dyspareunia is estimated to vary from 3 to 18% worldwide.[1]

Age

  • Patients of all age groups may develop [disease name].
  • The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
  • [Disease name] commonly affects individuals younger than/older than [number of years] years of age.
  • [Chronic disease name] is usually first diagnosed among [age group].
  • [Acute disease name] commonly affects [age group].

Race

  • There is no racial predilection to [disease name].
  • [Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].

Gender

  • Dyspareunia affects women more than men. It can be seen in men rarely.
  • Although clinical data suggest that dyspareunia can begin during adolescence, no large-scale epidemiological study has been conducted yet with this population.

Region

  • The majority of [disease name] cases are reported in [geographical region].
  • [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].

Developed Countries

The prevalence of dyspareunia in the United States is approximately 10% to 20%, with the underlying causes varying by age group.

Developing Countries

References

  1. Mitchell KR, Geary R, Graham CA, Datta J, Wellings K, Sonnenberg P, Field N, Nunns D, Bancroft J, Jones KG, Johnson AM, Mercer CH (October 2017). "Painful sex (dyspareunia) in women: prevalence and associated factors in a British population probability survey". BJOG. 124 (11): 1689–1697. doi:10.1111/1471-0528.14518. PMC 5638059. PMID 28120373.

Template:WH Template:WS